Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05737628
Title First-in-human Dose Escalation and Expansion Study With the SIRPalpha-directed Monoclonal Antibody BYON4228
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Byondis B.V.
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | ITA | GBR | ESP


No variant requirements are available.